Physician profile
Kent Vu
NPI 1003293820
$10,630.34
in general payments reported to CMS, 2019-2025
6 companies · $1,078 in 2025
The $1,078 reported for 2025 was more than what 94% of Anesthesiology providers received nationally (typical 2025 total: $58.09).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $49.49 · 2020: $1,809 · 2021: $4,415 · 2022: $1,400 · 2023: $1,800 · 2024: $80.15 · 2025: $1,078.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Consulting Fee: $1,800 · Travel and Lodging: $819 · Food and Beverage: $339.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Consulting Fee | $1,800.00 |
| Travel and Lodging | $819.10 |
| Food and Beverage | $338.55 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Edwards Lifesciences Corporation | $9,314.55 | 2020-2023 | |
| Abbott Laboratories | $930.80 | 2025 | Triclip |
| Haemonetics Corporation | $146.70 | 2025 | Teg6s Hemostasis System |
| Merck Sharp & Dohme LLC | $108.65 | 2020 | |
| Avanos Medical | $80.15 | 2024 | On-Q* Pump and Accessories |
| Boston Scientific Corporation | $49.49 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Kent Vu listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.